Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis

Autor: Wilco de Jager, Angelo Ravelli, Nico M Wulffraat, Richard van Wijk, Elisabetta Cortis, Fabrizio De Benedetti, Berent J. Prakken, Wietse Kuis, Silvia Magni-Manzoni, Wouter W. van Solinge, L E D'Urbano, Karen M.K. de Vooght, Sebastiaan J. Vastert, Antonella Insalaco
Rok vydání: 2009
Předmět:
Cytotoxicity
Immunologic

Cytotoxicity
Arthritis
Adolescent
Arthritis

Juvenile Rheumatoid
complications/immunology
Cells

Cultured
Child
Child

Preschool
Cytotoxicity

Immunologic
Genetic Predisposition to Disease
Genotype
Humans
Infant
Killer Cells

Natural
immunology
Macrophage Activation Syndrome

etiology/genetics/immunology
Mutation
Pore Forming Cytotoxic Proteins

biosynthesis/genetics
Promoter Regions

Genetic
Transfection

biosynthesis/genetics
medicine.disease_cause
immunology
Immunologic
Missense mutation
Killer Cells
Pharmacology (medical)
Child
Promoter Regions
Genetic

Cells
Cultured

Mutation
Cultured
biology
Macrophage Activation Syndrome
Killer Cells
Natural

medicine.anatomical_structure
Child
Preschool

Pore Forming Cytotoxic Proteins
complications/immunology
Adolescent
Genotype
Cells
Transfection
Natural killer cell
Promoter Regions
Rheumatology
Genetic
medicine
Humans
Genetic Predisposition to Disease
Preschool
business.industry
Perforin
Infant
medicine.disease
Systemic-onset juvenile idiopathic arthritis
Arthritis
Juvenile

etiology/genetics/immunology
Macrophage activation syndrome
Immunology
biology.protein
business
Juvenile rheumatoid arthritis
Zdroj: Rheumatology (Oxford, England). 49(3)
ISSN: 1462-0332
Popis: Objective Macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic arthritis (SoJIA) is considered to be an acquired form of familial haemophagocytic lymphohistiocytosis (fHLH). FHLH is an autosomal recessive disorder, characterized by diminished NK cell function and caused by mutations in the perforin gene (PRF1) in 20-50% of patients. Interestingly, SoJIA patients display decreased levels of perforin in NK cells and diminished NK cell function as well. Here, we analysed PRF1 and its putative promoter in SoJIA patients with or without a history of MAS. Methods DNA of 56 SoJIA patients (41 Italian and 15 Dutch) was isolated. Of these, 15 (27%) had a confirmed history of MAS. We sequenced PRF1 and 1.5 kb of the 5'-upstream region. DNA sequence variations in the promoter region were functionally tested in transfection experiments using a human NK cell line. Results We detected a previously undescribed sequence variation (-499 C > T) in the promoter of PRF1 in 18% of the SoJIA patients. However, transfection experiments did not show functional implications of this variation. Secondly, we found that 11 of 56 (20%) SoJIA patients were heterozygous for missense mutations in PRF1. In particular, we found a high prevalence of the Ala91Val mutation, a variant known to result in defective function of perforin. Interestingly, the prevalence of Ala91Val in SoJIA patients with a history of MAS (20%) was increased compared with SoJIA patients without MAS (9.8%). One SoJIA patient, heterozygous for Ala91Val, showed profound decreased perforin levels at the time of MAS. Conclusions These findings suggest that PRF1 mutations play a role in the development of MAS in SoJIA patients.
Databáze: OpenAIRE